Drug Metabolizing Enzymes and Genetic Variances in Pharmacogenomics
Author Information
Author(s): Wu Alan HB
Primary Institution: Department of Laboratory Medicine, University of California, San Francisco
Hypothesis
Understanding the relationship between drug metabolizing enzyme activities and genetic polymorphisms is crucial for personalized medicine.
Conclusion
The study highlights the importance of genetic variations in drug metabolizing enzymes for optimizing drug therapy and avoiding adverse effects.
Supporting Evidence
- Genetic polymorphisms in drug metabolizing enzymes can significantly affect drug efficacy and safety.
- Pharmacogenomic testing can help tailor drug therapy to individual genetic profiles.
- Understanding enzyme activity can prevent adverse drug reactions in patients.
Takeaway
Some people process medicines differently because of their genes, which can make them feel better or worse when taking the same medicine.
Methodology
The review discusses various drug metabolizing enzymes and their genetic polymorphisms, focusing on their clinical relevance.
Limitations
The review does not cover all possible metabolic pathways and genetic variants.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website